HZNP

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HZNP

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
10/16/2023	4:44PM	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/09/2023	7:33AM	IH Market News	Monday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and more	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	6:21PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	6:17PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	6:08PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	6:03PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	6:01PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	5:59PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	5:54PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	5:51PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:30PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:28PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:26PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:24PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:22PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:20PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:18PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:16PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:13PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:11PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:08PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/06/2023	8:30AM	Business Wire	Rule 17(e) Announcement - Horizon Therapeutics plc	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/05/2023	7:40AM	Business Wire	Rule 17(d) Announcement – Horizon Therapeutics plc	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/05/2023	7:32AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/03/2023	11:15AM	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/03/2023	11:06AM	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/02/2023	11:39AM	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/02/2023	11:24AM	Business Wire	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company
10/02/2023	8:00AM	Business Wire	Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023	NASDAQ:HZNP	Horizon Therapeutics Public Limited Company